Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2343)
All Articles published online
|
Publishing Process of This Article
|
Feb 15, 2025 (publication date) through Jan 17, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Li HY, Wang Y, Ran M, Gao F, Zhu BY, Xiao HY, Xu C. Tacrolimus induces insulin receptor substrate 1 hyperphosphorylation and inhibits mTORc1/S6K1 cascade in HL7702 cells. World J Diabetes 2025; 16(2): 97910 [PMID: 39959267 DOI: 10.4239/wjd.v16.i2.97910] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Li HY, Wang Y, Ran M, Gao F, Zhu BY, Xiao HY, Xu C. Tacrolimus induces insulin receptor substrate 1 hyperphosphorylation and inhibits mTORc1/S6K1 cascade in HL7702 cells. World J Diabetes 2025; 16(2): 97910 [PMID: 39959267 DOI: 10.4239/wjd.v16.i2.97910] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i2/97910.htm |
| Number | Citing Articles |
| 1 |
Lu Han, Die Zhang, Weidong Xiao, Chunyan Zeng, Youxiang Chen. PIK3CG deficiency promotes metabolic reprogramming in pancreatic Cancer by suppressing GLS2-driven glutamine metabolism. International Immunopharmacology 2026; 172: 116106 doi: 10.1016/j.intimp.2025.116106
|